Fora Capital, LLC Intra Cellular Therapies, Inc. Transaction History

Fora Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$54.67 - $66.44 $325,833 - $395,982	-5,960 Reduced 41.7%	8,332 $527,000
Q1 2023 May 12, 2023	BUY	$43.8 - $56.99 $625,989 - $814,501	14,292 New	14,292 $773,000
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $40,926 - $60,548	-1,425 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$29.3 - $44.5 $41,752 - $63,412	1,425 New	1,425 $58 Million
Q4 2020 Feb 12, 2021	SELL	$23.34 - $32.22 $127,273 - $175,695	-5,453 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$17.61 - $31.86 $43,426 - $78,566	-2,466 Reduced 31.14%	5,453 $140 Million
Q2 2020 Aug 14, 2020	BUY	$14.35 - $26.64 $113,637 - $210,962	7,919 New	7,919 $203 Million

378

84.7M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.92B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.